Euclidean Technologies Management’s Gilead Sciences GILD Stock Holding History

Euclidean Technologies Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$262K	Hold	3,153	–	–	0.24%	60
2022 Q4	$271K	Buy	+3,153	New	+$250K	0.26%	53
2022 Q1	–	Sell	-3,153	Closed	-$229K	–	87
2021 Q4	$229K	Hold	3,153	–	–	0.19%	72
2021 Q3	$220K	Hold	3,153	–	–	0.19%	65
2021 Q2	$217K	Buy	+3,153	New	+$211K	0.17%	80
2020 Q2	–	Sell	-22,375	Closed	-$1.67M	–	62
2020 Q1	$1.67M	Sell	22,375 -10,000	-31%	-$691K	2.76%	3
2019 Q4	$2.1M	Sell	32,375 -1,900	-6%	-$124K	2.18%	10
2019 Q3	$2.17M	Hold	34,275	–	–	2.04%	12
2019 Q2	$2.32M	Hold	34,275	–	–	2.18%	11
2019 Q1	$2.23M	Buy	+34,275	New	+$2.28M	2.06%	8

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Euclidean Technologies Management's GILD Position: Q1 2023 in Review

Euclidean Technologies Management held its Gilead Sciences (GILD) position steady in Q1 2023 at 3,153 shares worth $262K. The position accounts for 0.24% of the portfolio, ranked #60.

Euclidean Technologies Management first reported a position in GILD in Q1 2019 and has held it in 10 quarters since. The position peaked at $2.32M in Q2 2019. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Euclidean Technologies Management held 3,153 shares of Gilead Sciences worth $262K as of Q1 2023.
Euclidean Technologies Management left its Gilead Sciences share count unchanged in Q1 2023.
Gilead Sciences made up 0.24% of Euclidean Technologies Management's portfolio in Q1 2023, its #60 holding.
Euclidean Technologies Management first reported a position in Gilead Sciences in Q1 2019 and has held it in 10 quarters since.
Euclidean Technologies Management's Gilead Sciences position peaked at $2.32M in Q2 2019.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Euclidean Technologies Management's 13F filing for Q1 2023, filed 26 Apr 2023.